Work

Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency

Year: 2006

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Immunology

DOI: 10.1007/s10875-006-9025-3

Authors: Joseph A. Church, Heinz Leibl, Mark R. Stein, Isaac R. Melamed, Arye Rubinstein, Lynda C. Schneider, Richard L. Wasserman, Borislava G. Pavlova, Karl Birthistle, Marianne Mancini, Sandor Fritsch, Lisa Patrone, Kerry Moore-Perry, Hartmut J. Ehrlich, the US-PID-IGIV 10% -Study Group10

Institutions: Children's Hospital Los Angeles, Baxter (Austria), Allergy Associates of the Palm Beaches, Albert Einstein College of Medicine, Boston Children's Hospital, Baxter (United States)

Language: English

Topic: Immunodeficiency and Autoimmune Disorders

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2018036110

FWCI: 2.018

Cites: 23

Cited by: 80

Related to: 10